2019 Dallas Meeting Masthead

2019 Official Proceedings (pdf)

View All Accepted Abstracts

20th Annual Meeting Poster Gallery

April 30–May 5, 2019, Dallas, TX

Posters currently available to view online are listed at the top of the sections below. Posters PDFs are added as they are received. You can search for a poster by author, poster number, or title.

Hide unavailable posters

Age Extremes

581459Quantifying the relationship between age at diagnosis and risk of breast cancer-specific mortality.Helen Johnson
575735Screening Mammography Remains Effective among Older WomenBrittany Murphy
581715Breast Cancer Biology, Stage of Presentation, and Treatment in the Extremes of AgeJennifer Plichta
581617Effect of Hospital Volume on Overall Survival after Surgery in Elderly Breast Cancer PatientsSam Thalji
582034Treatment trends in early breast cancer in elderly women in the US between 2005 and 2015 using the NCDBWaed Alswealmeen 
581577Comparing tumor characteristics and treatment among young women with breast cancer: Age <35 versus 35-40Jesse Casaubon
580161A Ten-Year Review of Non-Operative Management for Hormone-Receptor Positive Breast Cancer in Elderly PatientsRebekah Macfie
578799Sentinel Lymph Node Biopsy in the Elderly Patient with Breast Cancer: Who Needs It?Autumn Shobe
580246Are We Overtreating Young Women with Early Stage Breast Cancer who Elect Mastectomy over Breast Conservation Surgery?Audree Tadros


582217Assessing the Clinical Outcomes of a Multidisciplinary Benign Breast ConferenceWill Gunderson
581845Benign papilloma excised at an NAPBC-accredited breast center: analysis of local upgrade rates for use in patient counselingRubie S. Jackson
576226Lactational phlegmon: a distinct clinical entity within the mastitis-abscess spectrumKatrina Mitchell
580505Cryotherapy for Benign Breast Lesions - Preliminary Results of a Single Center ExperienceRichard Wagner
581713Benign intraductal papilloma: is surgical excision warranted?Siun Walsh
531044Upgrade rates of atypical ductal hyperplasia and flat epithelial atypia in core-needle biopsies in a community hospital with a large minority populationMicaela Weaver
581821Does previous history of cancer or atypia predict histologic upgrade for pure intraductal papillomas diagnosed via core biopsy? A study of 511 cases at a single institutionJamie Alberty-Oller
582159Timing Reduction Mammaplasty in the Adolescent PatientJoseph Firriolo
582177The Mother Infant Lactation Questionnaire (MILQ): A Validated Instrument to Assess Breastfeeding PerformanceJoseph Firriolo
575396Benign, Atypical, and Malignant Breast Adenomyoepithelioma: A Single Institution’s ExperienceNaomi Wiens


581677Short-term complications and their risk factors after breast surgery utilizing the NSQIP databaseAshley Marumoto


578969Striving to Do No Harm and yet Respect Patient Autonomy: Plastic Surgeons’ Perspectives of the Consultation for Breast Reconstruction with Women Who Have Early Stage Breast CancerSelina Schmocker
576730Contralateral prophylactic mastectomies lead to increased surgical complications: a coarsened exact matching analysis of the national surgical quality improvement program (NSQIP) database.Maryam Elmi
581622Does Bilateral Mastectomy Improve Psychosocial Outcomes and Satisfaction Among Unilateral, Non-Hereditary Breast Cancer Patients?Catherine Pesce

Current Accruing Prospective Clinical Trials

581918Radioactive Iodine Seed Localization in Axilla with Sentinel Node Biopsy (RISAS): A Prospective Trial on Axillary Staging After Neoadjuvant Chemotherapy in Node Positive Breast CancerJanine Simons
577360Pre-mastectomy radiotherapy feasibility trial to facilitate immediate autologous breast reconstruction: A prospective cohort within a randomized clinical trialPuneet Singh
581643Interim Analysis of the DCISionRT PREDICT Study: Clinical Utility of a Biologic Signature Predictive of Radiation Therapy Benefit in Patients with DCISTroy Bremer
581738Eliminating Narcotic Use with Institutional Enhanced Recovery After Surgery (ERAS) Protocol in Autologous Breast Reconstruction Patients Following Mastectomy: A Pilot StudyChristopher McGreevy


582075Tumor-Infiltrating Lymphocytes in a Contemporary Cohort of Women with DCISAlison Price
579850A Comparison of Local Recurrence Risk Estimates After Breast-Conserving Surgery for DCIS: DCIS Nomogram Vs Refined Oncotype DX Breast DCIS Score™Kimberly J. Van Zee
581911Is sentinel lymph node biopsy necessary in patients with ductal carcinoma undergoing mastectomy?Alessandra Mele
582005Local Recurrences After Treatment for Ductal Carcinoma in Situ: Comparing Four Different Treatment ModalitiesAzadeh Carr
581618Factors Which May Predict Complete Removal of DCIS on Diagnostic Core Needle BiopsyEmil Fernando
576124Physician Comfort and Knowledge Level Regarding Observation of Ductal Carcinoma In Situ at Accredited Breast Centers.Elizabeth Poli


578645Is Metabolic Syndrome associated with decreased survival in African American breast cancer patients?Jennifer Bayron
557095Advanced Stage at Presentation in Breast Cancer Patients in a Rural, Resource-Limited StateJennifer Bishop
581889Safety Net Hospital Designation Influences Worse Survival Rates in Breast CancerCarissia Calvo
581029Disparities in the Surgical Treatment of Breast Cancer: A SEER Population-Based StudyAshley DiPasquale
581523The Influence of State Funded Cancer Care Treatment Program on Clinical Outcomes in Breast Cancer Patients Danier Moore
582078Institutional Variations in the Treatment of Early-Stage Breast CancerApoorve Nayyar
582201Breast Tumors in Obese Women Have Worse Prognostic FeaturesSusanna Nazarian
581633Bankruptcy among Indiana Breast Cancer patients: who is at risk?Samilia Obeng-Gyasi
581593Implications of Race on Presentation, Treatment, and Survival among Non-Metastatic Indiana Breast Cancer patientsSamilia Obeng-Gyasi
581921Characteristics of Hispanic Breast Cancer Patients in an Urban SettingKatherine Ottaviano
581880Genetic Variants Among Minority Patients Kathryn Ottaviano
581031Evaluation of Age and Stage at Time of Breast Cancer Diagnosis Between Racial Groups in a Safety Net Hospital: Are current screening recommendations missing the mark in underserved, racially diverse populations? Hayoung Park
581613Breast cancer in Chinese women: a comparative analysis Luona Sun


581929Defining Expectations of Future Biopsy and Frequency of Benign or Malignant Results of BRCA1/2 Positive Patients Undergoing Active SurveillanceKareen Ayre
581809Clinical management of high-risk breast cancer patients with variants of uncertain significance in the era of multigene panel testing Jenny Chang
580976Genetic Risk and Compliance with Risk Reduction in a High Risk Breast PopulationAmy Pratt
578732Choosing High-Risk Screening vs. Surgery and the Effect of Treatment Modality on Anxiety and Breast-Specific Sensuality in BRCA Mutation CarriersKristin Rojas
582132Genetic Screening Intervention: Identifying Carrier Status with a History of CancerRobin Sanders
581461Clinical and pathological features of breast cancer among men and women with ATM and CDH1 mutations Ashley Tsang
577316Prophylactic bilateral mastectomy and bilateral salpingo-oophorectomy in BRCA1/2 mutation carriersJessica Haddad
582196Polygenic risk scores in breast cancer risk assessment: clinical experience and management challengesJohn Zimmerman


580961Low Dose Molecular Breast Imaging (MBI) in the Surgical Setting: Initial Clinical ExperienceStanley Pollak
581535Follow-up and Diagnosis of Breast Incidentalomas on Abdominal and Chest MRISamantha Rios
581319Overuse of Pre-Operative Staging in Patients Undergoing Neoadjuvant Chemotherapy for Breast CancerMarissa Srour
580846Predicting pathologic nodal response following neoadjuvant chemotherapy for invasive breast cancer utilizing sequential axillary nodal imaging techniques.Marielle Ferstenberg
581700Moving Breast MRI Requests to Primary Care While Avoiding Unnecessary TestsCary Kaufman
581630Cryoablation alone for breast cancer: early results from the FROST trial. Elaine Jayne Buckley
580448Detectibility and Usefulness of Breast Ultrasound in Capsular Contracture DiagnosisJae Hong Kim
579428Ultrasonographic Evaluation With Breast Implant Checklist After Breast AugmentationAngela Soeun Lee
580531Impact of biennial versus annual mammography screening on breast cancer stage at diagnosis, after stratifying for riskBriana Leung
582074The Effect of Ultrasound Screening on Malignant Breast Lesions after Implementation of the Dense Breast Notification Law Pabel Miah
580685: Breast cancer detection using multimodality breast cancer screening techniques is influenced by breast tissue densityMegan Obi


581771Does bracketing reduce positive margin rates in patients undergoing partial mastectomy?Anees Chagpar
581815Results of a phase I, prospective, non-randomized study evaluating a Magnetic Occult Lesion Localization Instrument (MOLLI) for excision of non-palpable breast lesionsNicole Look Hong
580503Radiofrequency Identification Tag Localization is Comparable to Wire Localization for Non-Palpable Breast Lesions Caroline McGugin
581650Prospective Trial of Magnetic Seed Localization of Clipped NodesJanine Simons
582194Reflector Localized Axillary Lymph Node Biopsy: A Novel Aide in Axillary Staging After Neoadjuvant Chemotherapy for Node-Positive Breast CancerTara Balija
580284Management of focal mastectomy flap thickness in breast cancer patients: a novel approachErica Giblin
580274Radar localization for targeted excision of suspicious axillary lymph nodesErica Giblin
581780Utilizing Business Intelligence and Lean System Applications to Improve Efficiency in Breast SurgeryMaggie Hannah
579879Intraoperative Ultrasound Guidance with an US Visible Clip: a Practical and Cost-Effective Option for Breast Cancer LocalizationJohn Konen
582088I. Intraoperative wire needle localization of non- palpable lesions: experience in a public hospital in São Paulo, Brazil Danielle Martin Matsumoto
581631Hospital system rollout and initial experience with stainless steel magnetized seeds for breast and lymph node localizationMegan Megan
581934Savi Scout vs Wire Localization: Is one more efficient for OR utilization?Ashley A. Woodfin


581227Outcomes of Selective Whole Breast Irradiation Following Lumpectomy with Intraoperative Radiation Therapy for Hormone Receptor Positive Breast Cancer Kristy Kummerow Broman
582052Long-term survival following sentinel lymph node biopsy in clinically node negative breast cancer patients treated with primary surgery or neoadjuvant chemotherapyJanine Simons
582114Impact of progesterone receptor status on rates of recurrence in oestrogen receptor positive breast cancer patients – a systematic review and meta-analysisMichael Boland
582170Does Managing Vitamin D (VD) Levels Improve Outcomes in Breast Cancer Patients?Jessica Gooch


582008The Use of Bioimpedance Spectroscopy in the Evaluation of Simplified Lymphatic Microsurgical Preventing Healing Approach (S-LYMPHA) for the Prevention of Lymphedema After Axillary Lymph Node DissectionAhkeel Allen
581562Long Term Analysis of Lymphedema Diagnosed with Bioimpedance in Patients with Early Stage Breast CancerLisa Poole

Male Breast Cancer

582055How Often is the Nipple Areolar Complex Involved in Male Breast Cancer Patients? Breaking the Myth. Lucy De La Cruz
582433Demographic, Clinical, and Survival Disparities in Males with Metastatic Breast CancerAustin Williams


581432Impact of Consensus Guidelines for Breast-Conserving Surgery in DCISAbby Tremelling
581798MarginProbe Use Reduced Positive Margins and Lumpectomy VolumesCalvin Ridgeway
581663The Case for MarginProbe in the Era of No Ink on Tumor - Impact on Re-Excision and Tissue Volume Using Radiofrequency Spectroscopy Post Consensus GuidelinesRhonda Wachsmuth
581642Differences in Re-excision Rates for Breast Conserving Surgery using Intraoperative 2D vs. 3D Tomosynthesis Specimen Radiograph Andrea Colton
581586Accuracy of Intraoperative Gross Margin Assessment in Partial MastectomyJohn Konen
581967Can imaging-guided selective margin resection during lumpectomy for invasive breast cancer result in low re-excision rates?Natalie McClintock


577947Changes in Surgical Management Over Time in Breast Cancer Patients Treated with Neoadjuvant ChemotherapyMinna Lee
577343Survival Outcomes in Patients with Complete Response Following Neoadjuvant Chemotherapy: is Omitting Surgery an Option?Enver Ozkurt
581935Breast cancer with a higher proportion of tumor cells staining positive for Her2 is more likely to have complete pathologic response and better clinical outcome after neoadjuvant chemotherapy. Maria Pomponio
576750Patterns in Utilization of Axillary Operations in Patients with Node-Positive Breast Cancer Following Neoadjuvant Chemotherapy: A National Cancer Database (NCDB) AnalysisMarissa Srour
582099Impact of progesterone receptor status on response to neoadjuvant chemotherapy in oestrogen receptor positive breast cancer patients - should we be changing our approach?Michael Boland
577632Is MRI an Accurate Predictor of Nodal Status after Neoadjuvant Chemotherapy?Chandler Cortina
582126Time to Initiation of neoadjuvant chemotherapy for breast cancer treatment does not influence patient survival: a National Cancer Database studyDevon Livingston-Rosanoff
570881De-escalation of breast surgery after neoadjuvant therapy for breast cancer – could we do better?Emily Mackay
574500Impact of Surgical Timing on Postoperative Complications Following Neoadjuvant Chemotherapy for Breast CancerTom Sutton


578873Breast specific sensuality and appearance satisfaction: A comparison of breast conserving surgery and nipple sparing mastectomyJesse Casaubon
581255Three years of follow up in 52 patients with nipple-sparing mastectomy after neoadjuvant chemotherapy.Leonardo Paese Nissen


581739Minimally invasive breast surgery through unique incision approach for early breast cancer - an analytical description of 94 cases.Silvio Bromberg
581592Evaluating need for additional imaging and biopsy after oncoplastic breast conserving surgeryAngelena Crown
581609Oncoplastic Neoareolar Reduction Mammoplasty with Immediate Nipple Reconstruction: Expanding Indications for Breast Conserving TherapyAngelena Crown
563975Bilateral paravertebral nerve blocks are associated with reduced opioid use and pain scores after Level 2 volume displacement oncoplastic breast surgery.Liz Lin
581807Effectiveness and safety attributable to oncoplastic surgery as an adjuvant therapy for idiopathic granulomatous mastitis due to breast tuberculosisMirian Pinto Paz
580119Chest Wall Perforator Flap For Partial Breast Reconstruction: Value Addition For Oncoplastic Techniques Sanjit Agrawal
582101Assessing the impact of a hands-on oncoplastic course on surgeons’ practices Fernando Angarita
582104Oncoplastic surgery is not associated with increased complications when compared to standard breast conserving surgery: An analysis of the NSQIP databaseFernando Angarita
581340Intraoperative Continuous Ultrasonography Guided Oncoplastic Surgery: Margin Assessment and Selective Cavity Shaving Aktug Buzkan
581559Breast conserving surgery with partial breast reconstruction or reduction mammoplasty followed by whole breast radiation therapy (WBRT). Lisa Chapa
581953Patient Satisfaction with Breasts Following Single Stage Oncoplastic Reduction Mammoplasty—Does Radiation Impact BREAST-Q?Cory Donovan
581515Prepectoral One Stage Breast Reconstruction: single institution patient outcomes in 113 consecutive casesAyesha Khan
581040Interest in Oncoplastic Surgery Within Breast Surgical Oncology and Plastic SurgeryYurie Sekigami
581107Initial Experience of Round Block Mammoplasty (RBM) for Benign and Malignant Tumors: Is It The First Step to Advanced Oncoplasty in Low/Middle Income Countries (LMICs)?Salim Soomro
573638Oncoplastic level 2 mammoplasty for large DCIS: five-year resultsRFD van la Parra


580724Outcomes of Oncoplastic Breast Surgery Compared to Breast Conserving Surgery in Breast Cancer PatientsNafasat Farooqi
581261Intraoperative ketorolac use does not increase the risk of bleeding complications in breast surgeryThais Fortes
581241Patient-reported symptoms in the perioperative period of breast cancer treatment Courtney Fulton
582157Implementing a Safe and Feasible Ambulatory Mastectomy ProgramJenna Gillen
581186Generating awareness among Indian population through survivors: an innovative model for developing countries.Agnimita Giri Sarkar
5781055 Years of a Successful Peer Mentor Survivor Program Dona Hobart
580700Limiting narcotics for breast cancer patients: a prospective studyAmani Jambhekar
576195Outpatient surgery for breast cancer: Experience and outcome in 425 consecutive patients in a private breast clinic Ryungsa Kim
581607Flat Epithelial Atypia Identified on Core Needle Biopsy Does not Require ExcisionClaire Liu
581635A Systematic Review of Breast Cancer Risk in Transgender Patients After Top Surgery Mara Piltin
580350Performance and reporting variability in technical standards for breast cancer operationsSirivan Seng
581861Intraoperative Liposomal Bupivacaine Intercostal Blocks vs Paravertebral Blocks for Pain Control in Patients Undergoing Mastectomy with Implant-based ReconstructionEmily Siegel
581956Regional anesthetic block PECS II: Applicability of an intraoperative technique in breast cancer surgery patients in BrazilJonathan Maesaka
581689A European Union Approach to Harmonizing and Quality Improvement of Breast Cancer CareCary Kaufman
578320Decreasing Adjuvant Chemotherapy Use in Patients >50 Years of Age with Early Stage Breast Cancer: A Single-Institution Application of the TAILORx Study FindingsShahrzad Abbassi-Rahbar
581962New Breast Cancer AJCC Staging Eighth Edition Reflects Cancer Aggressiveness and Immune Response Mariko Asaoka
581151Idiopathic Granulomatous Mastitis: A closer look at demographic characteristics and factors associated with recurrence in 474 patientsArmina Azizi
582059Overview of treatment regimen and survival in patients with angiosarcoma of the breastAshton Brooks
581848Breast Enhanced Recovery After Surgery (BERAS) Protocol Decreases Immediate Postoperative Narcotic UtilizationMichelle Bryan
582144Compliance with Anti-hormonal Therapy After Omission of Radiation Following Breast Conserving Surgery in Favorable Older Patient SubgroupJessica Burns
582156Managing Necrotizing Fasciitis of the Breast: Is a Radical Approach Always Necessary?Daniela Cocco
581465Implementation of an Enhanced Recovery After Surgery (ERAS) protocol improves post-operative nausea and analgesia following total mastectomyKate Dinh
580096Evolving role of Oncotype DX ® following TailoRxAnjuli Gupta
581639Identifying Practice Patterns in the Utilization of FDG PET/CT for Staging Breast Cancer Patients at a Safety Net HospitalTran Ho
581229Symptoms following surgery for early stage breast cancer patients: A retrospective cohort study Claire Holloway
581670Understanding the Biology of Occult Breast Cancer: Examination of 31 Cases Finds Aggressive BehaviorMayo Hotta
581779Single surgeon vs co-surgeon bilateral mastectomy: A comparison of operative times, postoperative nausea, narcotic usage, and length of stayLaura Hudson
580463Comparison of normal Ultrasonographic findings of Most Commonly used Textured Breast Implants in KoreaHye Jin Kim
581564The Standardization of Outpatient Procedure (STOP) Narcotics: A prospective health systems intervention to reduce opioid use in ambulatory breast surgerySarah Knowles
581811Re-classification with the AJCC 8th edition staging system improves outcome prediction for patients with anatomic stage II disease and favorable tumor biology Amanda Kupstas
581556Predictors of axillary node response in clinically node-positive patients undergoing neoadjuvant chemotherapy for breast cancerFarah Ladak
581883Application of a mind-body tool in a rural population to improve post-operative outcomes in women with breast cancer: A pilot study.David Linshaw
581766The Impact of Oncotype DX in Invasive Lobular Carcinoma of the Breast – An Institutional ExperienceChristopher McGreevy
580460Axillary Reverse Mapping with Indocyanine Fluorescence Imaging System in Breast Cancer Patients with Clinically Negative NodesMasakuni Noguchi
582204Orthotopic implantation achieves better engraftment rate and faster growth than subcutaneous implantation in breast cancer patient-derived xenografts.Maiko Okano
575545Opioid Use After Breast Conserving Surgery: Identifying Risk Factors For High Opioid UseKo Un Park
582001Same day discharge for mastectomy-is it safe?: A population-based analysisMay Lynn Quan
581801Practice Changing Potential of TAILORx: A Retrospective Review of NCDB from 2010-2015. Sylvia A. Reyes
582199Benefits of an Interview Match for Breast Fellowship PositionsIrene Wapnir
578960Customized breast cancer risk assessment in an ambulatory clinic – a portal for identifying women at riskAnna Weiss

Patient Education

579398Evaluating Effectiveness of a Breast Cancer Survivorship Program - Quality Improvement Pilot StudyDibendu Betal
581794Statin Use At Time of Breast Cancer Diagnosis Is Associated With Better OutcomesAnn Chuang
580387Anxiety Scores of Women with an Increased Risk of Breast Cancer Participating in Facilitated Group Visits Kathryn Trotter
581276Contralateral Prophylactic Mastectomy: What's on the Other Side?Samantha Warwar


580331Fibroepithelial lesions of the breast diagnosed on core needle biopsy: do all patients require excision?Jodi Oostra


580686Complication rates after intraoperative radiation therapy: do applicator size and distance to skin matter?Amani Jambhekar
581161Can post-mastectomy radiation therapy be omitted in T1-2 clinically node negative breast cancer patients with a positive sentinel lymph node biopsy?Kate Dinh
581950Nuclear Grade: An Important Predictor of Local Recurrence in Patients Treated with Intraoperative Radiation Therapy (IORT)Melinda Epstein
582042A single institution review of APBI using brachytherapy versus IORT: a patterns of care analysisLauren Kopicky
581514Twelve Percent of SAVI Catheters Required Explantation Prior to Completion of Abbreviated Partial Breast Irradiation (APBI) Treatment in a Mature Community APBI ProgramDanier Moore
578618Improved Survival with Breast Conservation: Analysis of a Large National DatabaseChristopher Tokin


581636Hyperbaric (HBO) Treatment Reduces the Area of Ischemic Tissue in Compromised Flaps Post-MastectomyTammy Ju
580078Acellular dermal matrices as an adjunct to implant breast reconstruction: an evaluation of outcomes and complicationsMarios Konstantinos Tasoulis
582082Enhanced Recovery after Surgery Protocol Demonstrates Improved Pain Control and Reduced Opioid Consumption for Women Undergoing Mastectomy with Immediate Reconstruction John Edwards
581690Is Your Post-Mastectomy Patient Missing Something? The Global Success of Knitted KnockersCary Kaufman
580368Reoperation and Postoperative Outcomes for Single-Stage versus Two-Stage Breast Reconstruction Following Mastectomy: A Meta-AnalysisRenee Aboushi
580703Evaluating Patient Satisfaction in Autologous Breast Reconstruction vs. Implant ReconstructionMelissa Danko
582158Make Your Own DIEP: Perforator Delay Improves DIEP Flap Reliability.Lucy De La Cruz
581826Reduced Acute Complications Associated with Implant-Based Prepectoral Reconstruction after Nipple Sparing MastectomyKayla Griffith
581258The impact of post-operative prophylactic antibiotics in immediate 2-stage prepectoral breast reconstructionJami Rothman
576324Aesthetic outcomes and patient satisfaction following nipple-sparing vs skin-sparing, bilateral risk-reducing mastectomies: an 18 year study.Victoria Teoh
582131The Impact of Shared Decision Making on Patient Satisfaction Following Breast ReconstructionMichelle Wakeley


580510Development of Criteria for Omission of Surgical Axillary Staging in Low-risk Breast Cancer PatientsSuzanne Hoekstra
580657Lack of clinical utility for sentinel lymph node biopsy in contralateral prophylactic mastectomies with in situ carcinoma or atypiaAmani Jambhekar
582153Slow Uptake of Surgeons Using Intraoperative Radioisotope Injection for Sentinel Lymph Node BiopsySherry Johnson
580621Nomogram incorporating axillary ultrasound characteristics can identify a subgroup of patients unlikely to benefit from sentinel lymph node biopsyHanh-Tam Tran
582163Management of Positive Sentinel Lymph Node Biopsy following MastectomyAlessandra Mele
581972Implementation of Sentinel Lymph Node Biopsy Following Neoadjuvant Chemotherapy in Clinically Node Positive Breast CancerStephanie Serres
580075Sentinel Lymph Node Mapping in Breast Cancer After Neoadjuvant Chemotherapy: A Single Institution Experience.Joseph El Bourgi
574696Lobular Histology Does Not Predict the Need for Axillary Dissection Among ACOSOG Z0011-Eligible Breast CancersAnita Mamtani


556984Axillary Lymph Node Management in the Era of Neo-adjuvant Chemotherapy, Neo-endocrine treatment, and Targeted Axillary DissectionDiane Durgan
581509Sentinel Lymph Node Removal after Neoadjuvant Chemotherapy: When to Stop?Brittany Murphy
581445Lymph node marking with 4% carbon suspension before neoadjuvant chemotherapy: a new optionLucas Roskamp Budel
582086Favorable local control in breast cancer patients following sentinel lymph node biopsy after neoadjuvant chemotherapy without axillary lymph node dissectionNeslihan Cabioglu
581270National Trends in the use of Sentinel Node Biopsy after Neoadjuvant Chemotherapy in the United StatesGabrielle Gauvin
581599Should Sentinel Lymph Node Dissection be Offered after Neoadjuvant Therapy in Breast Cancer Patients with N3 Disease at Diagnosis?Neha Goel
582123Is Sentinel Lymph Node Biopsy Possible After Neoadjuvant Chemotherapy in Clinically-Responsive Inflammatory Breast Cancer PatientsSade (Folasade) Imeokparia

Stage IV

582162Primary Tumor Resection in De Novo Stage IV Breast Cancer Patients: Single Academic Center ExperienceClare Humphrey

Time to Treatment

580155Screening Mammograms in Palpable Breast Cancers Delays Time to TreatBetty Fan
578532Treatment times in breast cancer patients receiving neoadjuvant versus adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy?Nicole Melchior
581493Single-Day, Single-Site Multidisciplinary Approach for Complex Breast CancerRichard Gilmore
581797Improving wait times and patient experience through implementation of a provincial early referral system for women with BI-RADS 5 breast lesionsAlison Laws
581484The Impact of Time to First Breast Cancer Surgery on SurvivalKara Vande Walle

Tumor Genetics

581957Role of Oncotype DX® Recurrence Score in Predicting Nodal Response after Neoadjuvant Chemotherapy in Breast CancerAlessandra Mele
581864Women with higher BMI do not have higher Recurrence Score in a Single Institution SeriesMaria Pomponio
580452Association of a genomic index of sensitivity to endocrine therapy with locoregional recurrence of breast cancerPuneet Singh
581862Should the Oncotype DX DCIS Assay be Routinely Used for Shared Decision Making for Radiation Following Surgery in DCIS?Cynthia Chen
581558Epigenetic Subtyping of Triple Negative Breast Cancers: Clinical and Pathological Implications Maggie DiNome
582290Low AR expression tumors in ER positive tumors were enriched DNA repair related gene and it might be associated with patients’ survival.Maiko Okano
582234ANXA1 expression was associated with worse progress in Basal like breast cancer Maiko Okano
582079PLK1, polo-like kinase 1, is significantly associated with worse prognosis resulting from activated cell cycle and DNA repair deficiency in breast cancerTakashi Takeshita